Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2514]

Penn studies show hope for multiple cancers with pembrolizumab combination therapies

Penn studies show hope for multiple cancers with pembrolizumab combination therapies

FDA approves pembrolizumab for relapsed/cisplatin ineligible metastatic urothelial carcinoma

FDA approves pembrolizumab for relapsed/cisplatin ineligible metastatic urothelial carcinoma

Early MRI may lower costs for prostate cancer treatment

Early MRI may lower costs for prostate cancer treatment

ASCO 2017: Deficiencies in repair of DNA identified in many types of solid tumours

ASCO 2017: Deficiencies in repair of DNA identified in many types of solid tumours

Breakthrough study stops fat-eating prostate cancer cells

Breakthrough study stops fat-eating prostate cancer cells

Patients feel mightier with SWORD: behavioural therapy trial reduces fear of relapse

Patients feel mightier with SWORD: behavioural therapy trial reduces fear of relapse

Simple post-surgery step significantly reduces bladder cancer recurrence

Simple post-surgery step significantly reduces bladder cancer recurrence

European Association of Urology and Alliance for Personalised Medicine to put prostate cancer high on the agenda

European Association of Urology and Alliance for Personalised Medicine to put prostate cancer high on the agenda

FDA grants accelerated approval to avelumab for urothelial carcinoma

FDA grants accelerated approval to avelumab for urothelial carcinoma

Scrib protein identified as a natural suppressor of liver cancer

Scrib protein identified as a natural suppressor of liver cancer

More from ecancer